findmyKOL
Clinical trialNCT05838846CompletedPhase 2/PHASE3Interventional

Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgery

SponsorMenoufia UniversityEnrollment60Inhaled MilrinoneIntravenous MilrinoneMitral Valve ReplacementPulmonary Hypertension
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Egypt
  • Menoufia University Hospitals

    Shibīn al Kawm, Menoufia, Egypt

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Apr 2023
Primary completion
1 Jan 2025
Completion
1 Jan 2025
Last update posted
11 Feb 2025
Registered enrollment
60
Registry id
NCT05838846

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.